Nasal & Throat hygiene become the new norm in a post-COVID world, Q&A

Nasal & Throat hygiene become the new norm in a post-COVID world, Q&A 131 - America Out Loud News

In an article in America Out Loud News, Peter McCullough MD, cardiologist, is never reticent about creative thinking and looking for treatments that are unusual and tend to not be recommended by experts who follow paradigms and cookbook treatments the safest alternatives other than continuing vaccinations for COVID

Many others, including Robert Malone, MD, and Steven Hirsh experts were criticized, canceled, and ridiculed by physicians and others.

CofixRx Nasal Spray was developed by a board-certified anesthesiologist with the assistance and advisory information of seven other physicians. They also worked with a compounding pharmacist and pharmaceutical-grade manufacturer. It contains Povidone-Iodine and a mucoadhesive. Povidone is a well-known antiseptic used for preoperative sterilization of skin. The mucoadhesive is a polysaccharide solution. The initial formula was tested at Utah State University Institute of Antiviral Research and found to have amazing (95% or greater) antiviral properties against SARS-CoV-2, Delta, Omnicron, Influenza, Rhinovirus (common cold), RSV, and HRV 14. The spray lasts for hours in the nasal passages because of another special characteristic of the product’s ingredients. The ingredients also create a polysaccharide solution, which is a mucoadhesive. The mucoadhesive does three things. It creates a physical barrier to prevent viruses, bacteria, and allergens (like pet dander, pollen, mold spores, etc.) from adhering to and irritating the mucous membrane. Then, it allows the povidone-iodine to NOT get absorbed for hours, keeping it on the surface of the nasal passages where it does the best. Finally, it provides a moisturizing effect when combined with Vitamin D3.

There are some unanswered questions about what this spray does to the normal bacteria in the nose and throat, and for how long patients can use this spray.

Those figures exceed the effectiveness of masking and vaccination. It also prevents infection from other viruses...Influenza, Rhinovirus (common cold) RSV and HRV14.

James Bragman, DOFACP, is a board-certified member of the American Board of Internal, Geriatric, and Sports Medicine and has been working with CofixRx since its inception. He is a Full Clinical Professor of Internal Medicine at Wayne State University School of Medicine and an Assistant Clinical Professor at Michigan State University.